Andrea Caricasole, Kedrion BioPharma

: Jan 21, 2021

Looking for Partnership Looking for Extra EU Funds
About Me

Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of

Andrea Caricasole. Scientist with 15 years experience in neurodegeneration, including line management, networking and project leadership experience. I have worked in all preclinical phases of the drug discovery process, with a focus on target/mechanism validation and preclinical PoC development. Interests: plasma-derived therapies and recombinant analogues for rare diseases, rare disease diagnostics (point of care assays in particular), protein misfolding diseases (Huntington's disease, Parkinson's disease, Alzheimer's disease), post-translational modifications.

Keywords and matching areas:

 Biological Sciences
 Innovation & Research
 Medical Biotechnology

Ideas in Progress
No ideas yet!
Favourite Calls
No Favourite calls!